Select top biotech drugs based on revenue 2022
Best-selling biotech drugs worldwide
AbbVie’s Humira is among the top selling biotechnology drugs in the world, generating over 21 billion U.S. dollars in 2022. Biotechnology has become more prevalent within the pharmaceutical industry. One of the first uses of biotechnology was for human insulin. The United States had around 1,500 dedicated biotechnology companies in 2020. Among the larger biotechnology companies in the world is Switzerland-based company Roche. The company generated some 41 billion U.S. dollars in biotech prescription drug revenues in 2019 and is expected to reach over 48 billion U.S. dollars in 2026. One of its long-time best-selling drugs, Avastin, generated about 2.1 billion U.S. dollars in revenue in 2022. Avastin is a drug derived from biotechnology that is used to inhibit the growth of new blood vessels to treat some types of cancer.
The United States spent about 88 billion U.S. dollars on research and development in the biotechnology sector in 2020. The United States also had about 38 percent of the world’s share of filed biotechnology patents in 2019, in comparison, Germany filed around six percent of global biotech patents.